Showing posts with label Complete Genomics. Show all posts
Showing posts with label Complete Genomics. Show all posts

Monday, August 8, 2011

Fluor (FLR) (PKI) (DLB) (ARCC) (GNOM) (SD) Price Targets Changed

Fluor Co. (NYSE: FLR), PerkinElmer, Inc. (NYSE: PKI), Dolby Labs (NYSE: DLB), Ares Capital (NASDAQ: ARCC), Complete Genomics (NASDAQ: GNOM) and SandRidge Energy Inc. (NYSE: SD) price targets adjusted by analysts.

Fluor Co. (FLR) had its price target raised by Credit Suisse (NYSE:CS) to $86.00. They have an “Outperform” rating on the company.

PerkinElmer, Inc. (PKI) had its price target lowered by UBS AG (NYSE:UBS) from $31.00 to $28.00. They have a “Buy” rating on the company.

Dolby Labs (DLB) had its price target lowered by Canaccord Genuity from $54.00 to $33.00. They have a “Hold” rating on the company.

Ares Capital (ARCC) had its price target lowered by Citigroup (NYSE:C) to $17.00. They have a “Buy” rating on the company.

Complete Genomics (GNOM) had its price target lowered by UBS AG from $15.00 to $8.50. They have a “Neutral” rating on the company.

SandRidge Energy Inc. (SD) had its price target lowered by UBS AG to $10.00. They have a “Neutral” rating on the company.